ArticleProceedings of the National Academy of Sciences of the United States of America2006

A model of acquired autoresistance to a potent ErbB2 tyrosine kinase inhibitor and a therapeutic strategy to prevent its onset in breast cancer.

Wenle Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.